Published in Am J Trop Med Hyg on October 01, 2002
Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J (2009) 2.67
Prevalence and risk factors of anaemia among children aged between 6 months and 14 years in Kenya. PLoS One (2014) 1.48
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda. Malar J (2008) 1.24
Shifting from presumptive to test-based management of malaria - technical basis and implications for malaria control in Ghana. Ghana Med J (2014) 1.21
Clustering of under-five mortality in the Navrongo HDSS in the Kassena-Nankana District of northern Ghana. Glob Health Action (2010) 1.15
Malaria epidemiology in the Ahafo area of Ghana. Malar J (2011) 1.08
Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin Vaccine Immunol (2008) 1.07
Factors associated with malaria parasitemia, anemia and serological responses in a spectrum of epidemiological settings in Uganda. PLoS One (2015) 0.96
Seasonal prevalence of malaria in West Sumba district, Indonesia. Malar J (2009) 0.95
A longitudinal study on anaemia in children with Plasmodium falciparum infection in the Mount Cameroon region: prevalence, risk factors and perceptions by caregivers. BMC Infect Dis (2013) 0.95
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa. Malar J (2015) 0.84
Effect of Plasmodium falciparum malaria parasites on haematological parameters in Ghanaian children. J Parasit Dis (2014) 0.75
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature (2002) 8.92
Verbal autopsy: current practices and challenges. Bull World Health Organ (2006) 6.66
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96
Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med (2006) 5.28
Primaquine therapy for malaria. Clin Infect Dis (2004) 4.66
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science (2013) 4.60
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action (2012) 3.68
Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Setting priorities in global child health research investments: guidelines for implementation of CHNRI method. Croat Med J (2008) 3.42
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J (2007) 3.24
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A (2011) 2.83
Accelerating reproductive and child health programme impact with community-based services: the Navrongo experiment in Ghana. Bull World Health Organ (2006) 2.82
Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin Infect Dis (2006) 2.76
Revising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoring. Glob Health Action (2013) 2.69
Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J (2009) 2.67
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature (2002) 2.49
Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg (2003) 2.49
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis (2002) 2.40
TDR thirty years on: taking stock and envisioning the future for the Special Programme for Research and Training in Tropical Diseases. PLoS Negl Trop Dis (2008) 2.39
Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci U S A (2003) 2.38
Core verbal autopsy procedures with comparative validation results from two countries. PLoS Med (2006) 2.36
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet (2007) 2.36
Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol (2003) 2.32
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet (2012) 2.21
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One (2008) 2.19
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial. Am J Clin Nutr (2009) 2.04
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One (2010) 2.03
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet (2006) 2.00
Socio-cultural determinants of treatment delay for childhood malaria in southern Ghana. Trop Med Int Health (2006) 1.99
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis (2007) 1.94
Demographic Surveillance Sites and emerging challenges in international health. Bull World Health Organ (2006) 1.93
Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg (2002) 1.91
The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J Infect Dis (2009) 1.87
The need for new antibiotics. Lancet (2010) 1.85
The impact of the Navrongo Project on contraceptive knowledge and use, reproductive preferences, and fertility. Stud Fam Plann (2002) 1.73
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? Malar J (2007) 1.72
Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA (2012) 1.71
Comparative analysis of apicomplexa and genomic diversity in eukaryotes. Genome Res (2004) 1.71
Patterns of age-specific mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med Hyg (2007) 1.70
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS One (2008) 1.68
Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar J (2007) 1.67
Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana. Trop Med Int Health (2003) 1.67
Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana. Malar J (2010) 1.65
Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One (2009) 1.65
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics. Malar J (2013) 1.64
An exploratory study of factors that affect the performance and usage of rapid diagnostic tests for malaria in the Limpopo Province, South Africa. Malar J (2007) 1.63
Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg (2012) 1.62
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J (2010) 1.58
The safety of artemisinins during pregnancy: a pressing question. Malar J (2007) 1.54
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother (2008) 1.50
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes. Hum Mol Genet (2009) 1.50
Gate-keeping and women's health seeking behaviour in Navrongo, northern Ghana. Afr J Reprod Health (2003) 1.48
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS One (2008) 1.48
Community-based surveillance: a pilot study from rural Cambodia. Trop Med Int Health (2005) 1.48
Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania. PLoS One (2010) 1.46
Unstable malaria transmission and maternal mortality--experiences from Rwanda. Trop Med Int Health (2002) 1.42
Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res (2009) 1.42
Haemoglobin and haematocrit: is the threefold conversion valid for assessing anaemia in malaria-endemic settings? Malar J (2007) 1.40
Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis (2008) 1.39
The changing patterns of hypertension in Ghana: a study of four rural communities in the Ga District. Ethn Dis (2006) 1.39
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial. PLoS One (2009) 1.38
Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malar J (2008) 1.37
Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malar J (2008) 1.36
Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect Immun (2005) 1.34
Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health (2010) 1.34
Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe. PLoS One (2013) 1.33
Estimating the burden of malaria in pregnancy: a case study from rural Madhya Pradesh, India. Malar J (2009) 1.33
The natural progression of Gambiense sleeping sickness: what is the evidence? PLoS Negl Trop Dis (2008) 1.31
A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis (2010) 1.31
Primaquine for prevention of malaria in travelers. Clin Infect Dis (2003) 1.31
Clinical case definitions and malaria vaccine efficacy. J Infect Dis (2005) 1.30
Socio-economic factors associated with the purchasing of insecticide-treated nets in Afghanistan and their implications for social marketing. Trop Med Int Health (2003) 1.30
Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy. BMC Public Health (2010) 1.29
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS One (2010) 1.28